Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CB 1 and CB 2 Receptor Pharmacology
A­llyn C. Howlett, Mary E. Abood
Advances in pharmacology (2017), pp. 169-206
Open Access | Times Cited: 296

Showing 1-25 of 296 citing articles:

Bioactive lipids, inflammation and chronic diseases
Alessandro Leuti, Domenico Fazio, Marina Fava, et al.
Advanced Drug Delivery Reviews (2020) Vol. 159, pp. 133-169
Closed Access | Times Cited: 244
Cannabidiol (CBD) as a Promising Anti-Cancer Drug
Emily S. Seltzer, Andrea Watters, Danny MacKenzie, et al.
Cancers (2020) Vol. 12, Iss. 11, pp. 3203-3203
Open Access | Times Cited: 200
Targeting Cannabinoid Receptors: Current Status and Prospects of Natural Products
Dongchen An, Steve Peigneur, Louise Antonia Hendrickx, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 14, pp. 5064-5064
Open Access | Times Cited: 165
In vitro and in vivo pharmacological activity of minor cannabinoids isolated from Cannabis sativa
Ayat Zagzoog, Kawthar A. Mohamed, Hye Ji J. Kim, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 146
Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years
Mauro Maccarrone, Vincenzo Di Marzo, Jürg Gertsch, et al.
Pharmacological Reviews (2023) Vol. 75, Iss. 5, pp. 885-958
Open Access | Times Cited: 91
2022 WSAVA guidelines for the recognition, assessment and treatment of pain
Beatriz P. Monteiro, B. Duncan X. Lascelles, Joanna C. Murrell, et al.
Journal of Small Animal Practice (2022) Vol. 64, Iss. 4, pp. 177-254
Open Access | Times Cited: 86
Structural basis of selective cannabinoid CB2 receptor activation
Xiaoting Li, Hao Chang, Jara Bouma, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 46
Cardiotoxic effects of common and emerging drugs: role of cannabinoid receptors
Yi-Ming Bo, Xin Zhao, Liliang Li
Clinical Science (2024) Vol. 138, Iss. 6, pp. 413-434
Closed Access | Times Cited: 24
Beta-Caryophyllene, a Cannabinoid Receptor Type 2 Selective Agonist, in Emotional and Cognitive Disorders
Caterina Ricardi, Serena Barachini, G. Consoli, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 6, pp. 3203-3203
Open Access | Times Cited: 17
Emerging paradigms for target discovery of traditional medicines: A genome-wide pan-GPCR perspective
Zenghao Bi, Huan Li, Yuting Liang, et al.
The Innovation (2025) Vol. 6, Iss. 3, pp. 100774-100774
Open Access | Times Cited: 3
New Insights in Cannabinoid Receptor Structure and Signaling
Lingyan Ye, Zheng Cao, Weiwei Wang, et al.
Current Molecular Pharmacology (2019) Vol. 12, Iss. 3, pp. 239-248
Open Access | Times Cited: 105
Cannabis: A Toxin-Producing Plant with Potential Therapeutic Uses
Zeinab Breijyeh, Buthaina Jubeh, Sabino Aurelio Bufo, et al.
Toxins (2021) Vol. 13, Iss. 2, pp. 117-117
Open Access | Times Cited: 84
Cannabinoid Receptor Type 2: A Possible Target in SARS-CoV-2 (CoV-19) Infection?
Francesca Rossi, Chiara Tortora, Maura Argenziano, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 11, pp. 3809-3809
Open Access | Times Cited: 77
Cannabis Bioactive Compound-Based Formulations: New Perspectives for the Management of Orofacial Pain
Giuseppina Crescente, Giuseppe Minervini, Carmela Spagnuolo, et al.
Molecules (2022) Vol. 28, Iss. 1, pp. 106-106
Open Access | Times Cited: 50
Role of the Endocannabinoid System in the Regulation of Intestinal Homeostasis
Hailey Cuddihey, Wallace K. MacNaughton, Keith A. Sharkey
Cellular and Molecular Gastroenterology and Hepatology (2022) Vol. 14, Iss. 4, pp. 947-963
Open Access | Times Cited: 49
Endocannabinoid System: Chemical Characteristics and Biological Activity
Bismarck Rezende, A Alencar, Graziele Freitas de, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 2, pp. 148-148
Open Access | Times Cited: 39
Mitochondria as central hubs in synaptic modulation
Filipe V. Duarte, Daniele Ciampi, Carlos B. Duarte
Cellular and Molecular Life Sciences (2023) Vol. 80, Iss. 6
Open Access | Times Cited: 31
Inhibiting degradation of 2-arachidonoylglycerol as a therapeutic strategy for neurodegenerative diseases
Chu Chen
Pharmacology & Therapeutics (2023) Vol. 244, pp. 108394-108394
Open Access | Times Cited: 28
CB2 receptor in the CNS: From immune and neuronal modulation to behavior
Wanda Grabon, Sylvain Rheims, Jonathon Smith, et al.
Neuroscience & Biobehavioral Reviews (2023) Vol. 150, pp. 105226-105226
Open Access | Times Cited: 28
Flipping the GPCR Switch: Structure-Based Development of Selective Cannabinoid Receptor 2 Inverse Agonists
Miroslav Kosar, Roman C. Sarott, David A. Sykes, et al.
ACS Central Science (2024) Vol. 10, Iss. 5, pp. 956-968
Open Access | Times Cited: 9
The Endocannabinoid System: Implications in Gastrointestinal Physiology and Pathology
Emanuela Aloisio Caruso, Valentina De Nunzio, Valeria Tutino, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 1306-1306
Open Access | Times Cited: 1
The Resurgence of Synthetic Cannabinoid Receptor Agonists as Adulterants in the Era of Cannabis Legalization: Lessons from Prior Epidemics and Clinical Implications
Aaron P. Jones, Ali S. Taha, Grover P. Miller
Neuroscience & Biobehavioral Reviews (2025), pp. 106043-106043
Closed Access | Times Cited: 1
Molecular Mechanism and Cannabinoid Pharmacology
Lesley D. Schurman, Dai Lu, Debra A. Kendall, et al.
Handbook of experimental pharmacology (2019), pp. 323-353
Open Access | Times Cited: 75
β-Caryophyllene, A Natural Dietary CB2 Receptor Selective Cannabinoid can be a Candidate to Target the Trinity of Infection, Immunity, and Inflammation in COVID-19
Niraj Kumar Jha, Charu Sharma, Hebaallah Mamdouh Hashiesh, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 56
Pro-Inflammatory Cytokines: Potential Links between the Endocannabinoid System and the Kynurenine Pathway in Depression
Ferenc Zádor, Sâmia R.L. Joca, Gábor Nagy-Grócz, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 11, pp. 5903-5903
Open Access | Times Cited: 45
Page 1 - Next Page

Scroll to top